• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血浆基质金属蛋白酶-1组织抑制剂对结直肠癌患者长期生存的影响。

Impact of plasma tissue inhibitor of matrix metalloproteinase-1 on long-term survival in patients with colorectal cancer.

作者信息

Yukawa Norio, Yoshikawa Takaki, Akaike Makoto, Sugimasa Yukio, Rino Yasushi, Masuda Munetaka, Imada Toshio

机构信息

Department of Surgery, Yokohama City University, Yokohama, Japan.

出版信息

Oncology. 2007;72(3-4):205-8. doi: 10.1159/000112827. Epub 2007 Dec 21.

DOI:10.1159/000112827
PMID:18160809
Abstract

Tissue inhibitor of metalloproteinase-1 (TIMP-1) not only inhibits matrix metalloproteinases but also stimulates tumor growth. In this study, long-term follow-up results were analyzed to clarify the prognostic value of plasma TIMP-1. Preoperative plasma TIMP-1 was measured from peripheral blood samples of 87 Japanese patients with colorectal carcinoma. All the patients underwent surgical resection and were followed for 5 years prospectively. The median follow-up period was 70 months (60-79 months). The cutoff value of plasma TIMP-1 was set at 170 ng/ml based on the ROC curve. Sensitivity and specificity to predict 5-year survival was 66.7 and 55.0% with this cutoff value. In univariate analyses for overall survival, lymph node metastasis, serosal invasion, peritoneal metastasis, liver metastasis, metastasis to other distant organs and TIMP-1 were significant. In multivariate analyses, lymph node and liver metastases, metastasis to other distant organs and plasma TIMP-1 were independent prognosticators, but p values of TIMP-1 did not reach statistical significance. Our results suggested that the preoperative plasma TIMP-1 concentration could be a useful prognosticator of long-term survival in patients with colorectal carcinoma.

摘要

金属蛋白酶组织抑制剂-1(TIMP-1)不仅能抑制基质金属蛋白酶,还能刺激肿瘤生长。在本研究中,分析了长期随访结果以阐明血浆TIMP-1的预后价值。从87例日本结直肠癌患者的外周血样本中检测术前血浆TIMP-1。所有患者均接受手术切除,并进行了5年的前瞻性随访。中位随访期为70个月(60-79个月)。根据ROC曲线,将血浆TIMP-1的临界值设定为170 ng/ml。以此临界值预测5年生存率的敏感性和特异性分别为66.7%和55.0%。在总生存的单因素分析中,淋巴结转移、浆膜侵犯、腹膜转移、肝转移、其他远处器官转移和TIMP-1具有显著性。在多因素分析中,淋巴结和肝转移、其他远处器官转移及血浆TIMP-1是独立的预后因素,但TIMP-1的p值未达到统计学显著性。我们的结果表明,术前血浆TIMP-1浓度可能是结直肠癌患者长期生存的有用预后指标。

相似文献

1
Impact of plasma tissue inhibitor of matrix metalloproteinase-1 on long-term survival in patients with colorectal cancer.血浆基质金属蛋白酶-1组织抑制剂对结直肠癌患者长期生存的影响。
Oncology. 2007;72(3-4):205-8. doi: 10.1159/000112827. Epub 2007 Dec 21.
2
Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with colorectal cancer.基质金属蛋白酶-1组织抑制剂对结直肠癌患者血浆的预后影响
Anticancer Res. 2004 May-Jun;24(3b):2101-5.
3
Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.术前血清基质金属蛋白酶(MMP - 2、MMP - 9)及基质金属蛋白酶组织抑制剂(TIMP - 1、TIMP - 2)分析在结直肠癌中的价值有限。
Anticancer Res. 2000 Mar-Apr;20(2B):1085-91.
4
Circulating gelatinases and tissue inhibitor of metalloproteinase-1 in colorectal cancer metastatic liver disease.循环明胶酶与金属蛋白酶组织抑制因子-1在结直肠癌肝转移疾病中的作用
Eur J Surg Oncol. 2006 Sep;32(7):756-63. doi: 10.1016/j.ejso.2006.03.028. Epub 2006 May 2.
5
Plasma concentration of tissue inhibitor of matrix metalloproteinase 1 in patients with colorectal carcinoma.结直肠癌患者基质金属蛋白酶1组织抑制剂的血浆浓度
Br J Surg. 2001 Dec;88(12):1596-601. doi: 10.1046/j.0007-1323.2001.01930.x.
6
High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.术前血浆金属蛋白酶组织抑制因子-1水平高与结直肠癌患者的生存期短相关。
Clin Cancer Res. 2000 Nov;6(11):4292-9.
7
Comparative studies of tissue inhibitor of metalloproteinases-1 in plasma, serum and tumour tissue extracts from patients with primary colorectal cancer.原发性结直肠癌患者血浆、血清及肿瘤组织提取物中金属蛋白酶组织抑制剂-1的比较研究。
Scand J Gastroenterol. 2008;43(2):186-91. doi: 10.1080/00365520701491355.
8
Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.胃癌患者血清中的基质金属蛋白酶组织抑制因子-1:一种潜在的预后生物标志物。
Ann Clin Lab Sci. 2006 Winter;36(1):23-30.
9
Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.基质金属蛋白酶9与核分级的显著关系以及金属蛋白酶组织抑制剂2对偶然发现的透明细胞肾细胞癌的预后影响
Urology. 2007 Jun;69(6):1049-53. doi: 10.1016/j.urology.2007.02.044.
10
Serum levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer patients.
Surg Today. 2003;33(12):885-92. doi: 10.1007/s00595-003-2628-x.

引用本文的文献

1
Elucidation of the anti-colorectal cancer mechanism of by network pharmacology and experimental verification.基于网络药理学和实验验证阐明 抗结直肠癌的作用机制。
Aging (Albany NY). 2024 Aug 22;16(16):12008-12028. doi: 10.18632/aging.206075.
2
In silico identification of single nucleotide variations at CpG sites regulating CpG island existence and size.通过计算机预测 CpG 位点单核苷酸变异对 CpG 岛存在和大小的调控作用。
Sci Rep. 2022 Mar 4;12(1):3574. doi: 10.1038/s41598-022-05198-8.
3
RNA-Seq Reveals Different Gene Expression in Liver-Specific Prohibitin 1 Knock-Out Mice.
RNA测序揭示肝脏特异性抑制素1基因敲除小鼠的不同基因表达
Front Physiol. 2021 Sep 3;12:717911. doi: 10.3389/fphys.2021.717911. eCollection 2021.
4
Circulating Biomarkers of Colorectal Cancer (CRC)-Their Utility in Diagnosis and Prognosis.结直肠癌(CRC)的循环生物标志物——它们在诊断和预后中的应用
J Clin Med. 2021 May 28;10(11):2391. doi: 10.3390/jcm10112391.
5
Tissue inhibitor of metalloproteinase-1 (TIMP-1) as a prognostic biomarker in gastrointestinal cancer: a meta-analysis.金属蛋白酶组织抑制剂-1(TIMP-1)作为胃肠道癌的预后生物标志物:一项荟萃分析。
PeerJ. 2021 Feb 16;9:e10859. doi: 10.7717/peerj.10859. eCollection 2021.
6
TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice.TIMP-1 在肝纤维化和肝癌形成中被上调,但不是必需的。
Sci Rep. 2017 Apr 6;7(1):714. doi: 10.1038/s41598-017-00671-1.
7
Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction.血清基质金属蛋白酶-1组织抑制剂水平与恶性大脑中动脉梗死患者的死亡率相关。
BMC Neurol. 2015 Jul 11;15:111. doi: 10.1186/s12883-015-0364-7.
8
The matrix metalloproteinase-7 and pro-enzyme of metalloproteinase-1 as a potential marker for patients with rectal cancer without distant metastasis.基质金属蛋白酶-7和金属蛋白酶-1原酶作为无远处转移直肠癌患者的潜在标志物。
Tumour Biol. 2015 May;36(5):3629-35. doi: 10.1007/s13277-014-3000-z. Epub 2014 Dec 31.
9
Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression.基质金属蛋白酶及其天然抑制剂在前列腺癌进展中的作用。
Cancers (Basel). 2014 Jun 27;6(3):1298-327. doi: 10.3390/cancers6031298.
10
TIMP-1 promotes accumulation of cancer associated fibroblasts and cancer progression.TIMP-1 促进癌症相关成纤维细胞的积累和癌症进展。
PLoS One. 2013 Oct 15;8(10):e77366. doi: 10.1371/journal.pone.0077366. eCollection 2013.